Constructs of burden of illness in older patients with breast cancer: A comparison of measurement methods

Health Services Research

Volumn 36, Issue 6 I, 2001, Pages 1085-1107

  Mandelblatt, J S ^a   Bierman, A S ^a   Gold, K ^a   Zhang, Y ^a   Ng, J H ^a   Maserejan, N ^a   Hwang, Y T ^a   Meropol, N J ^a   Hadley, J ^a   Silliman, R A ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

Breast cancer; Comorbidity; Elderly; Health status

Indexed keywords

TAMOXIFEN;

AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; FEMALE; HEALTH SERVICE; HEALTH STATUS; HUMAN; INTERMETHOD COMPARISON; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; PHYSICAL PERFORMANCE;

ACTIVITIES OF DAILY LIVING; AGE DISTRIBUTION; AGE FACTORS; AGED; ATTITUDE TO HEALTH; BREAST NEOPLASMS; COMORBIDITY; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; DISABLED PERSONS; DISTRICT OF COLUMBIA; FEMALE; GERIATRIC ASSESSMENT; HEALTH STATUS; HUMANS; LIFE EXPECTANCY; MASSACHUSETTS; NEW YORK; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; TEXAS; TREATMENT OUTCOME; WOMEN'S HEALTH;

EID: 0035663340     PISSN: 00179124     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. The impact of co-morbidity on life expectancy among men with localized prostate cancer
2. Monthly vital statistics report
3. Factors associated with surgical and radiation therapy for early stage breast cancer in older women
4. A convenient approximation of life expectancy (The 'DEALE'): I. Validation of the method
5. A convenient approximation of life expectancy (The 'DEALE'): II. Use in medical decision-making
6. Life expectancy, comorbidity, and quality of life. A framework of reference for medical decisions
7. Influence of age and comorbidity on treatment choice and survival in elderly patients with breast cancer
8. Comorbidity-adjusted complication risk: A new outcome quality measure
9. Preventing frail health
10. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
11. Angina patients' ratings of current health and health without angina: Associations with severity of angina and comorbidity
12. Correlates of early hospital readmission or death in patients with congestive heart failure
13. Problems of comorbidity in mortality after prostatectomy
14. Factors that determine the treatment for local and regional prostate cancer
15. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases
16. An additional dimension to health inequalities: Disease severity and socioeconomic position
17. Comorbidity measures for use with administrative data
18. Aging and cancer. Issues of basic and clinical science
19. Assessment of the older cancer patient
20. What threshold for adjuvant therapy in older breast cancer patients?
21. Comorbidity and functional status are independent in older cancer patients
22. Comorbidity of five chronic health conditions in elderly community residents: Determinants and impact on mortality
23. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer
24. The importance of physician communication on breast cancer screening of older women
25. Association of comorbidity with disability in older women: The women's health and aging study
26. Comorbidity in arthritis
27. A comparison of two comorbidity instruments in arthritis
28. Determinants of survival in older cancer patients
29. The importance of co-existent disease in the occurrence of postoperative complications and one-year recovery in patients undergoing total hip replacement. Comorbidity and outcomes after hip replacement
30. Flaws in mortality data. The hazards of ignoring comorbid disease
31. Patterns of care related to age of breast cancer patients
32. Development and testing of a new measure of case mix for use in office practice
33. How consistent is patient-reported preadmission health status when collected during and after hospital stay?
34. Age-related patterns of care: Evidence against ageism in the treatment of early-stage breast cancer
35. Life expectancy estimation with breast cancer: Bias of the declining exponential function and an alternative to its use
36. Can comorbidity be measured by questionnaire rather than medical record review?
37. Patterns of expenditures and use of services among older adults with diabetes. Implications for the transition to capitated managed care
38. Comparing comorbid-illness indices assessing outcome variation: The case of prostatectomy
39. Prevalence of cancer
40. Primary and secondary care management of women with early breast cancer from affluent and deprived areas: Retrospective review of hospital and general practice records
41. Proposed agenda for the measurement of quality-of-care outcomes in oncology practice
42. Patterns of breast carcinoma treatment in older women: Patient preferences and clinical and physical influences
43. Patterns of comorbidity and mortality risk in blacks and whites
44. The influence of age on clinical and patient-reported outcomes after cholecystectomy
45. The relationship between disease and function and perceived health in very frail elders
46. The effect of age and comorbidity in the treatment of elderly women with nonmetastatic breast cancer
47. Cancer statistics by race and ethnicity
48. Frailty bias in comorbidity risk adjustments of community-dwelling elderly populations
49. The effect of comorbidity on 3-year survival of women with primary breast cancer
50. The importance of comorbidities in explaining differences in patient costs
51. Comparison of interview-based and medical-record based indices of comorbidity among breast cancer patients
52. The impact of age, marital status, and physician-patient interactions on the care of older women with breast carcinoma
53. Severity of illness: Concepts and measurements
54. The MOS short-form general health survey: Reliability and validity in a patient population
55. Quantifying comorbidity in a disease-specific cohort: Adaptation of the total illness burden index to prostate cancer
56. Stage, age, comorbidity, and direct costs of colon, prostate, and breast cancer care
57. NIH consensus conference. Treatment of early breast cancer
58. Comorbidity and breast cancer survival: A comparison between black and white women
59. Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients